Companies by Sector - Pharmaceuticals and Biotechnology
| EPIC | Company | Index | Dividend Yield | Market Cap | Price Close | % Change |
|---|---|---|---|---|---|---|
| AZN | AstraZeneca | FTSE 100 | 1.99 | £185.97B | 11,844.00 | -1.22% |
| GSK | GSK | FTSE 100 | 3.74 | £77.98B | 1,896.00 | -1.63% |
| HLN | Haleon | FTSE 100 | 2.00 | £32.17B | 365.40 | 0.05% |
| HIK | Hikma Pharmaceuticals | FTSE 250 | 3.77 | £3.46B | 1,638.00 | -0.67% |
| HCM | Hutchmed China | AIM | £1.65B | 183.50 | 4.80% | |
| GNS | Genus | FTSE 250 | 1.38 | £1.54B | 2,296.00 | -0.95% |
| INDV | Indivior | FTSE 250 | £1.54B | 1,238.00 | -3.10% | |
| OXB | Oxford BioMedica | FTSE Small Cap | £579.2M | 487.00 | 1.78% | |
| AGY | Allergy Therapeutics | AIM | £348.29M | 5.45 | -2.50% | |
| AVCT | Avacta Group | AIM | £304.46M | 65.00 | -7.00% | |
| PRTC | Puretech Health | FTSE Small Cap | £290.32M | 120.20 | 1.18% | |
| ANCR | Animalcare Group | AIM | 0.66 | £231.3M | 335.00 | -2.60% |
| BTG | BTG | AIM | 4.30 | £172.67M | 106.00 | -0.10% |
| MXCT | Maxcyte Inc | AIM | £161.75M | 147.69 | -1.20% | |
| BMK | Benchmark Holdings | AIM | £135.69M | 22.05 | 1.50% | |
| DXRX | Diaceutics | AIM | £129.02M | 150.00 | -0.50% | |
| SCLP | Scancell Holdings | AIM | £115.16M | 9.60 | -1.10% | |
| ANP | Anpario | AIM | 2.43 | £104.18M | 510.00 | -0.90% |
| FARN | Faron Pharmaceuticals OY | AIM | £91.98M | 42.00 | 1.10% | |
| 4BB | 4basebio | AIM | £81.58M | 500.50 | -0.40% | |
| BVXP | Bioventix | AIM | 10.00 | £78.37M | 1,505.00 | -2.20% |
| OBI | Ondine Biomedical Inc | AIM | £71.44M | 13.70 | 2.60% | |
| EAH | Eco Animal Health Group | AIM | £65.73M | 98.20 | -4.30% | |
| POLB | Poolbeg Pharma | AIM | £63.82M | 8.25 | -2.10% | |
| ANIC | Agronomics | AIM | £58.5M | 5.40 | -0.60% | |
| HVO | Hvivo | AIM | £47.06M | 6.90 | -5.10% | |
| ABDX | Abingdon Health | AIM | £45.68M | 11.00 | 2.60% | |
| STX | Shield Therapeutics | AIM | £41.19M | 4.06 | -7.90% | |
| SAR | Sareum Holdings | AIM | £31.87M | 24.00 | -5.60% | |
| SBTX | SkinBioTherapeutics | AIM | £28.51M | 10.71 | -14.90% | |
| IMM | ImmuPharma | AIM | £23.24M | 3.70 | -3.00% | |
| AREC | Arecor Therapeutics | AIM | £22.09M | 62.00 | -1.30% | |
| EDEN | Eden Research | AIM | £19.68M | 2.40 | -2.40% | |
| GDR | Genedrive | AIM | £18.46M | 1.21 | -1.60% | |
| IXI | Ixico | AIM | £17.44M | 7.47 | -1.50% | |
| CEL | Celadon Pharmaceuticals | AIM | £9.23M | 13.40 | % | |
| AGL | Angle | AIM | £7.72M | 2.40 | -0.70% | |
| PRM | Proteome Sciences | AIM | £6.33M | 1.95 | 8.00% | |
| OPTI | OptiBiotix Health | AIM | £5.78M | 6.00 | -3.30% | |
| TRX | Tissue Regenix Group | AIM | £5.16M | 7.25 | -1.50% | |
| OBD | Oxford BioDynamics | AIM | £5.15M | 0.12 | -4.00% | |
| VRCI | Verici Dx | AIM | £5.15M | 0.25 | -4.80% | |
| VAL | ValiRx | AIM | £2.11M | 0.17 | -2.20% | |
| FUM | Futura Medical | AIM | £1.98M | 0.34 | 14.60% | |
| GUN | Gunsynd | AIM | £1.33M | 0.09 | 9.50% |